Qiagen N.V. Common Shares (QGEN) earnings
Quarterly and annual QGEN reports and results, each read against the price at its own news timestamp. Back to the QGEN overview →
7 measured QGEN earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook | Press release | -1.05% | -3.10% | |
| Qiagen Announces Form 20-F Annual Report Filing for 2025 Results | Press release | -0.87% | -0.99% | |
| QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase | Press release | +0.43% | +0.02% | |
| QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook | Press release | -1.05% | +2.86% | |
| QIAGEN N.V.: QIAGEN Announces Strong Preliminary Q1 2025 Results and Updates Full-Year 2025 Adjusted Earnings per Share Outlook | Press release | -1.05% | +2.86% | |
| QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results | Press release | +0.13% | +1.65% | |
| QIAGEN announces Form 20-F annual report filing for 2023 results | Press release | +0.20% | +0.81% |
Keep exploring
More QGEN: analyst actions → · SEC filings → · QGEN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Galapagos NV - American Depositary Shares (GLPG) | 267 | -0.05% | 44% |
| Eyenovia, Inc. (EYEN) | 266 | -0.95% | 38% |
| 22nd Century Group, Inc (XXII) | 266 | -1.87% | 30% |
| Cellectar Biosciences, Inc. (CLRB) | 265 | +0.27% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.